Nuclear medicine blood disorders. In nuclear medicine therapy, the radiation treatment dose is administered internally (e.g. intravenous or oral routes) rather than from an external radiation source. The radiopharmaceuticals used in nuclear medicine therapy emit ionizing radiation that travels only a short distance, thereby minimizing unwanted side effects and damage to noninvolved organs or nearby structures. Most nuclear medicine therapies can be performed as outpatient procedures since there are few side effects from the treatment and the radiation exposure to the general public can be kept within a safe limit. Common nuclear medicine (unsealed source) therapies In some centers the nuclear medicine
ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism captured by code from . ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism ICD-10 is an international statistical classification used in health care and related industries. Produced by the World Health Organization, it is used in several countries around the world. Some have gone on to develop their own national enhancements, building off the international version of the classification. Chapter III of ICD-10 deals with diseases of the blood, for example anaemia, blood-forming organs, and certain disorders involving the immune mechanism. Of note; blood cancers, such as leukaemia, are covered in